세포 독성약 시장 규모는 향후 수년간 강력한 성장세를 보이며 2029년까지 연평균 5.7%의 성장률(CAGR)로 203억 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 맞춤형 의료 접근법 채택, 암 전문 치료 센터 증가, 생활습관 변화로 인한 암 발병률 증가, 병용요법에 대한 수요 증가, 암 치료 및 연구 지원을 위한 정부의 구상 등에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 기존 화학요법에서 표적치료제로의 전환, 암 치료에서 생물제제 및 바이오시밀러의 사용 증가, 신약개발에 인공지능의 통합, 생명공학 기업과 학계의 공동연구 증가 등을 꼽을 수 있습니다.
표적 질환 증가는 향후 수년간 세포 독성약 시장의 성장을 촉진할 것으로 예상됩니다. 표적 질환은 환자의 예후를 개선하기 위해 집중적인 의학 연구, 치료 및 중재 노력의 초점이 되는 특정 질병 또는 상태를 말합니다. 대상 질환의 예로는 암, 자가면역질환, 유전성 질환 등이 있습니다. 대상 질환의 이환율 증가 요인으로는 유전적 소인, 환경적 요인, 불충분한 의료 접근성 등을 들 수 있습니다. 세포독성 약물은 질병을 유발하는 세포를 사멸시키거나 성장을 억제하여 그 증식과 확산을 억제함으로써 대상 질환의 발생 증가와 싸우는 데 중요한 역할을 합니다. 예를 들어 세계보건기구(WHO)의 암 전문 기관인 국제암연구소(IARC)가 발표한 자료에 따르면 2022년에는 전 세계에서 약 2,000만 명의 암 환자가 새로 발생하여 970만 명이 사망할 것으로 예측했습니다. 2050년까지 신규 환자는 77% 증가한 3,500만 명을 넘어설 것으로 예측했습니다. 특히 폐암과 여성 유방암은 2022년 전 세계에서 가장 높은 발병률을 보였습니다. 따라서 대상 질환의 발생이 증가하고 있는 것이 세포 독성약 시장 확대의 원동력이 되고 있습니다.
세포 독성약 시장의 주요 업체들은 키메라 항원 수용체(CAR) T 세포 요법과 같은 진보적이고 혁신적인 솔루션을 개발하여 특정 유형의 혈액암 환자에게 혁신적인 치료 옵션을 제공하기 위한 노력을 강화하고 있습니다. 암세포와 싸우기 위해 유전자 조작된 T세포를 사용하는 선구적인 치료 접근법으로 암 치료에 있으며, 중요한 돌파구가 될 수 있습니다. 예를 들어 2024년 3월 브리스톨 마이어스 스퀴브(Bristol-Myers Squibb)는 재발성 또는 불응성 만성 림프구성 백혈병(CLL) 또는 소림프구성 림프종(SLL) 성인 환자를 위한 CD19 지향성 CAR T세포 치료제인 Breyanzi의 FDA 승인을 발표했습니다. 이번 승인은 CD19 지향성 CAR T 세포 치료를 통한 맞춤 치료의 진보를 강조하며, 환자들에게 새로운 치료 경로와 효능을 제공할 수 있는 기회를 제공합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 세포 독성약PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 세포 독성약 시장 : 성장률 분석
- 세계의 세포 독성약 시장 실적 : 규모와 성장, 2019-2024
- 세계의 세포 독성약 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 세포 독성약 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 세포 독성약 시장 : 약제 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 알킬화제
- 항종양 항생제
- 대사 길항제
- 식물 알칼로이드
- 기타 약물 유형
- 세계의 세포 독성약 시장 : 테라피별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 화학요법
- 방사선 요법
- 면역치료
- 줄기세포 이식
- 기타 치료법
- 세계의 세포 독성약 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 종양학
- 류마티스 관절염
- 다발성 경화증
- 기타 용도
- 세계의 세포 독성약 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 암연구 센터
- 약물 검사 연구소
- 계약 개발 제조 조직(CDMO)
- 세계의 세포 독성약 시장, 알킬화제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 질소 머스터드
- 에틸렌이민
- 알킬 술폰산염
- 트리아젠
- 세계의 세포 독성약 시장, 항종양 항생제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Anthracyclines
- Bleomycin
- Mitomycin
- 세계의 세포 독성약 시장, 대사 길항제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Methotrexate
- 5-Fluorouracil
- 퓨린 유사체
- 세계의 세포 독성약 시장, 식물 알칼로이드의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Vinca Alkaloids
- Taxanes
- Camptothecin 유사체
- 세계의 세포 독성약 시장, 기타 약제 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 백금계 화합물
- 항체약물접합체(ADC)
- Nitrosoureas
제7장 지역별·국가별 분석
- 세계의 세포 독성약 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 세포 독성약 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 세포 독성약 시장 : 경쟁 구도
- 세포 독성약 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Novartis AG
- Sanofi S.A.
- Bristol-Myers Squibb Company
- AstraZeneca plc
- Fresenius Kabi AG
- GlaxoSmithKline Plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Boehringer Ingelheim International GmbH
- Merck KGaA
- Evonik Industries AG
- Teva Pharmaceutical Industries Ltd.
- Baxter International Inc.
- Daiichi Sankyo Company Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 세포 독성약 시장 2029 : 새로운 기회를 제공하는 국가
- 세포 독성약 시장 2029 : 새로운 기회를 제공하는 부문
- 세포 독성약 시장 2029 : 성장 전략
제36장 부록
KSA
Cytotoxic drugs constitute a class of medications designed to halt or eradicate rapidly proliferating cells, particularly cancer cells, by impeding their growth and division. They accomplish this by disrupting various biological processes, including metabolism, mitosis, and DNA replication. These drugs are frequently administered in conjunction with other therapeutic modalities such as surgery, radiation therapy, and targeted therapies to maximize treatment effectiveness and better manage cancer.
The primary types of cytotoxic drugs include alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others. Alkylating agents, for instance, are utilized in cancer treatment to induce DNA damage in cancer cells, thus inhibiting their ability to multiply. These drugs find application across various therapies such as chemotherapy, radiotherapy, immunotherapy, and stem cell transplantation, addressing conditions such as oncology, rheumatoid arthritis, multiple sclerosis, among others. They are utilized by a diverse range of end users including hospitals, cancer research centers, drug testing laboratories, and contract development and manufacturing organizations (CDMOs).
The cytotoxic drugs market research report is one of a series of new reports from The Business Research Company that provides cytotoxic drugs market statistics, including cytotoxic drugs industry global market size, regional shares, competitors with a cytotoxic drugs market share, detailed cytotoxic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the cytotoxic drugs industry. This cytotoxic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cytotoxic drugs market size has grown strongly in recent years. It will grow from $15.35 billion in 2024 to $16.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in the prevalence of cancer globally, the increase in healthcare expenditure, the growth of the aging population, the availability of government funding and grants, and the increased public awareness about cancer treatments.
The cytotoxic drugs market size is expected to see strong growth in the next few years. It will grow to $20.3 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the adoption of personalized medicine approaches, growth in the number of specialized cancer treatment centers, increasing incidence of cancer due to lifestyle changes, rising demand for combination therapies, and government initiatives supporting cancer treatment and research. Major trends in the forecast period include a shift towards targeted therapies over traditional chemotherapy, increasing use of biologics and biosimilars in cancer treatment, integration of artificial intelligence in drug discovery and development, and rise in collaborations between biotech firms and academic institutions.
The rising occurrence of target diseases is expected to drive the growth of the cytotoxic drugs market in the coming years. Target diseases refer to specific illnesses or conditions that are the focus of concentrated medical research, treatment, or intervention efforts aimed at improving patient outcomes. Examples of target diseases include cancer, autoimmune disorders, genetic conditions, and others. Factors contributing to the increased incidence of target diseases include genetic predisposition, environmental factors, and inadequate access to healthcare. Cytotoxic drugs play a crucial role in combating the increased occurrence of target diseases by either killing or inhibiting the growth of disease-causing cells, thereby curbing their proliferation and spread. For example, data published by the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization (WHO), revealed approximately 20 million new cancer cases and 9.7 million deaths worldwide in 2022. Projections suggest a staggering 77% increase to over 35 million new cases by 2050. Notably, lung cancer and female breast cancer were the most prevalent globally in 2022. Hence, the heightened occurrence of target diseases is a driving force behind the expansion of the cytotoxic drugs market.
Key players in the cytotoxic drugs market are intensifying their efforts to develop advanced and innovative solutions, such as chimeric antigen receptor (CAR) T cell therapies, to offer transformative treatment options for patients with specific types of blood cancer. CAR T cell therapy represents a pioneering treatment approach that employs genetically engineered T cells to combat cancer cells, marking a significant breakthrough in oncology therapeutics. For instance, in March 2024, Bristol Myers Squibb announced FDA approval of Breyanzi, a CD19-directed CAR T cell therapy for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This approval underscores the advancements in personalized medicine through CD19-directed CAR T cell therapy, providing new treatment avenues and improved efficacy for patients.
In March 2024, Johnson & Johnson acquired Ambrx Biopharma Inc. for approximately $2.0 billion, enhancing its oncology portfolio and prostate cancer innovation by leveraging Ambrx's advanced ADC (antibody-drug conjugate) technology. This technology combines specific monoclonal antibodies with potent chemotherapeutic payloads, augmenting Johnson & Johnson's capabilities in manufacturing cytotoxic drugs. Ambrx Biopharma Inc., a clinical-stage biopharmaceutical company based in the US, specializes in the development of cytotoxic drugs.
Major companies operating in the cytotoxic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Fresenius Kabi AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Merck KGaA, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Daiichi Sankyo Company Limited, Lonza, Eisai Co. Ltd., Sun Pharmaceuticals, Sumitomo Dainippon Pharma, Jazz Pharma, Ipsen Pharma, Kyowa Kirin Co. Ltd., Cipla Ltd., Mallinckrodt Pharmaceuticals, Hansoh Pharmaceutical Group Company Limited, Piramal Group
North America was the largest region in the cytotoxic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cytotoxic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cytotoxic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cytotoxic drugs market consists of sales of monoclonal antibodies, tyrosine kinase inhibitors, topoisomerase inhibitors, platinum-based drugs, proteasome inhibitors, and angiogenesis inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cytotoxic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cytotoxic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cytotoxic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cytotoxic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Alkylating Agents; Antitumor Antibiotics; Antimetabolites; Plant Alkaloids; Other Drug Types
- 2) By Therapy: Chemotherapy; Radiotherapy; Immunotherapy; Stem Cell Transplantation; Other Therapies
- 3) By Application: Oncology; Rheumatoid Arthritis; Multiple Sclerosis; Other Applications
- 4) By End User: Hospitals; Cancer Research Centers; Drug Testing Laboratories; Contract Development And Manufacturing Organizations (CDMOs)
- Subsegments:
- 1) By Alkylating Agents: Nitrogen Mustards; Ethyleneimines; Alkyl Sulfonates; Triazenes
- 2) By Antitumor Antibiotics: Anthracyclines; Bleomycin; Mitomycin
- 3) By Antimetabolites: Methotrexate; 5-Fluorouracil; Purine Analogs
- 4) By Plant Alkaloids: Vinca Alkaloids; Taxanes; Camptothecin Analogs
- 5) By Other Drug Types: Platinum-Based Compounds; Antibody-Drug Conjugates (ADCs); Nitrosoureas
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Roche Holding AG; Merck & Co.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cytotoxic Drugs Market Characteristics
3. Cytotoxic Drugs Market Trends And Strategies
4. Cytotoxic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cytotoxic Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cytotoxic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cytotoxic Drugs Market Growth Rate Analysis
- 5.4. Global Cytotoxic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cytotoxic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cytotoxic Drugs Total Addressable Market (TAM)
6. Cytotoxic Drugs Market Segmentation
- 6.1. Global Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alkylating Agents
- Antitumor Antibiotics
- Antimetabolites
- Plant Alkaloids
- Other Drug Types
- 6.2. Global Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Stem Cell Transplantation
- Other Therapies
- 6.3. Global Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Rheumatoid Arthritis
- Multiple Sclerosis
- Other Applications
- 6.4. Global Cytotoxic Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Cancer Research Centers
- Drug Testing Laboratories
- Contract Development And Manufacturing Organizations (CDMOs)
- 6.5. Global Cytotoxic Drugs Market, Sub-Segmentation Of Alkylating Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nitrogen Mustards
- Ethyleneimines
- Alkyl Sulfonates
- Triazenes
- 6.6. Global Cytotoxic Drugs Market, Sub-Segmentation Of Antitumor Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anthracyclines
- Bleomycin
- Mitomycin
- 6.7. Global Cytotoxic Drugs Market, Sub-Segmentation Of Antimetabolites, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Methotrexate
- 5-Fluorouracil
- Purine Analogs
- 6.8. Global Cytotoxic Drugs Market, Sub-Segmentation Of Plant Alkaloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vinca Alkaloids
- Taxanes
- Camptothecin Analogs
- 6.9. Global Cytotoxic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Platinum-Based Compounds
- Antibody-Drug Conjugates (ADCs)
- Nitrosoureas
7. Cytotoxic Drugs Market Regional And Country Analysis
- 7.1. Global Cytotoxic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cytotoxic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cytotoxic Drugs Market
- 8.1. Asia-Pacific Cytotoxic Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cytotoxic Drugs Market
- 9.1. China Cytotoxic Drugs Market Overview
- 9.2. China Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cytotoxic Drugs Market
- 10.1. India Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cytotoxic Drugs Market
- 11.1. Japan Cytotoxic Drugs Market Overview
- 11.2. Japan Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cytotoxic Drugs Market
- 12.1. Australia Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cytotoxic Drugs Market
- 13.1. Indonesia Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cytotoxic Drugs Market
- 14.1. South Korea Cytotoxic Drugs Market Overview
- 14.2. South Korea Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cytotoxic Drugs Market
- 15.1. Western Europe Cytotoxic Drugs Market Overview
- 15.2. Western Europe Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cytotoxic Drugs Market
- 16.1. UK Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cytotoxic Drugs Market
- 17.1. Germany Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cytotoxic Drugs Market
- 18.1. France Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cytotoxic Drugs Market
- 19.1. Italy Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cytotoxic Drugs Market
- 20.1. Spain Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cytotoxic Drugs Market
- 21.1. Eastern Europe Cytotoxic Drugs Market Overview
- 21.2. Eastern Europe Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cytotoxic Drugs Market
- 22.1. Russia Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cytotoxic Drugs Market
- 23.1. North America Cytotoxic Drugs Market Overview
- 23.2. North America Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cytotoxic Drugs Market
- 24.1. USA Cytotoxic Drugs Market Overview
- 24.2. USA Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cytotoxic Drugs Market
- 25.1. Canada Cytotoxic Drugs Market Overview
- 25.2. Canada Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cytotoxic Drugs Market
- 26.1. South America Cytotoxic Drugs Market Overview
- 26.2. South America Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cytotoxic Drugs Market
- 27.1. Brazil Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cytotoxic Drugs Market
- 28.1. Middle East Cytotoxic Drugs Market Overview
- 28.2. Middle East Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cytotoxic Drugs Market
- 29.1. Africa Cytotoxic Drugs Market Overview
- 29.2. Africa Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cytotoxic Drugs Market Competitive Landscape And Company Profiles
- 30.1. Cytotoxic Drugs Market Competitive Landscape
- 30.2. Cytotoxic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Cytotoxic Drugs Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi S.A.
- 31.3. Bristol-Myers Squibb Company
- 31.4. AstraZeneca plc
- 31.5. Fresenius Kabi AG
- 31.6. GlaxoSmithKline Plc
- 31.7. Takeda Pharmaceutical Company Limited
- 31.8. Eli Lilly and Company
- 31.9. Amgen Inc.
- 31.10. Boehringer Ingelheim International GmbH
- 31.11. Merck KGaA
- 31.12. Evonik Industries AG
- 31.13. Teva Pharmaceutical Industries Ltd.
- 31.14. Baxter International Inc.
- 31.15. Daiichi Sankyo Company Limited
32. Global Cytotoxic Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cytotoxic Drugs Market
34. Recent Developments In The Cytotoxic Drugs Market
35. Cytotoxic Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Cytotoxic Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cytotoxic Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cytotoxic Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
